215 related articles for article (PubMed ID: 30317943)
1. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients.
Wang JY; Zhang GJ; Zhuo SX; Wang K; Hu XP; Zhang H; Qu LD
Neurol Res; 2018 Nov; 40(11):948-954. PubMed ID: 30317943
[TBL] [Abstract][Full Text] [Related]
2. Voxel-Based Lesion Mapping of Cryptogenic Stroke in Patients with Advanced Cancer: A Detailed Magnetic Resonance Imaging Analysis of Distribution Pattern.
Achiha T; Takagaki M; Oe H; Sakai M; Matsui H; Nakanishi K; Ozaki T; Fujimoto Y; Yoshimine T; Nakanishi K; Kinoshita M
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1521-1527. PubMed ID: 28363514
[TBL] [Abstract][Full Text] [Related]
3. Clues to occult cancer in patients with ischemic stroke.
Kim SJ; Park JH; Lee MJ; Park YG; Ahn MJ; Bang OY
PLoS One; 2012; 7(9):e44959. PubMed ID: 22984594
[TBL] [Abstract][Full Text] [Related]
4. Ability of the number of territories involved on DWI-MRI to predict occult systemic malignancy in cryptogenic stroke patients.
Guo L; Wang L; Liu W
J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104823. PubMed ID: 32362555
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer.
Kono T; Ohtsuki T; Hosomi N; Takeda I; Aoki S; Sueda Y; Ishihara K; Nakamura T; Yamawaki T; Matsumoto M
Geriatr Gerontol Int; 2012 Jul; 12(3):468-74. PubMed ID: 22233138
[TBL] [Abstract][Full Text] [Related]
6. D-dimer and Body CT to Identify Occult Malignancy in Acute Ischemic Stroke.
Rosenberg J; Do D; Cucchiara B; Messé SR
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105366. PubMed ID: 33039769
[TBL] [Abstract][Full Text] [Related]
7. Ischemic stroke in patients with cancer: is it different from usual strokes?
Lee EJ; Nah HW; Kwon JY; Kang DW; Kwon SU; Kim JS
Int J Stroke; 2014 Jun; 9(4):406-12. PubMed ID: 23981525
[TBL] [Abstract][Full Text] [Related]
8. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
Yamamoto R; Nakae Y; Tanaka F; Johkura K
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
[TBL] [Abstract][Full Text] [Related]
9. D-dimer and C-reactive Protein as Potential Biomarkers for Diagnosis of Trousseau's Syndrome in Patients with Cerebral Embolism.
Tsushima M; Metoki N; Hagii J; Saito S; Shiroto H; Yasujima M; Kato T; Kudo N; Toyama Y; Yokono Y; Nozaka M; Kawamura Y; Nakata M; Tomita H
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104534. PubMed ID: 31810721
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Imaging Characteristics of Malignant Tumor Concurrent with Stroke.
Wang F; Hu XY; Cui ZM; Fang XM; Dai Z; Wang T; Guo DL
Cancer Biother Radiopharm; 2019 Oct; 34(8):504-510. PubMed ID: 31295003
[No Abstract] [Full Text] [Related]
11. Impact of Elevated D-Dimer on Diagnosis of Acute Aortic Dissection With Isolated Neurological Symptoms in Ischemic Stroke.
Yoshimuta T; Yokoyama H; Okajima T; Tanaka H; Toyoda K; Nagatsuka K; Higashi M; Hayashi K; Kawashiri MA; Yasuda S; Yamagishi M
Circ J; 2015; 79(8):1841-5. PubMed ID: 25993997
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study.
Guo YJ; Chang MH; Chen PL; Lee YS; Chang YC; Liao YC
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e249-54. PubMed ID: 24295603
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and prognostic factors of patients with cancer-associated stroke.
Sawada J; Katayama T; Kikuchi-Takeguchi S; Kano K; Saito M; Mitsui N; Hiroshima S; Kinoshita M; Nakagawa N
Neurol Sci; 2024 Jun; 45(6):2747-2757. PubMed ID: 38267601
[TBL] [Abstract][Full Text] [Related]
14. D-dimer levels and cerebral infarction in critically ill cancer patients.
Ryu JA; Bang OY; Lee GH
BMC Cancer; 2017 Aug; 17(1):591. PubMed ID: 28854911
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke.
Kang DW; Yoo SH; Chun S; Kwon KY; Kwon SU; Koh JY; Kim JS
Stroke; 2009 May; 40(5):1653-8. PubMed ID: 19265045
[TBL] [Abstract][Full Text] [Related]
16. Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes.
Kang DW; Chalela JA; Ezzeddine MA; Warach S
Arch Neurol; 2003 Dec; 60(12):1730-4. PubMed ID: 14676047
[TBL] [Abstract][Full Text] [Related]
17. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea.
Kim SG; Hong JM; Kim HY; Lee J; Chung PW; Park KY; Kim GM; Lee KH; Chung CS; Bang OY
Stroke; 2010 Apr; 41(4):798-801. PubMed ID: 20150545
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors, Biomarkers, Etiology, Outcome and Prognosis of Ischemic Stroke in Cancer Patients.
Sorgun MH; Kuzu M; Ozer IS; Yilmaz V; Ulukan C; Cotur Levent H; Tezcan S; Rzayev S; Rawandi A; Bakırarar B; Isikay CT
Asian Pac J Cancer Prev; 2018 Mar; 19(3):649-653. PubMed ID: 29580034
[TBL] [Abstract][Full Text] [Related]
19. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology.
Schwarzbach CJ; Schaefer A; Ebert A; Held V; Bolognese M; Kablau M; Hennerici MG; Fatar M
Stroke; 2012 Nov; 43(11):3029-34. PubMed ID: 22996958
[TBL] [Abstract][Full Text] [Related]
20. D-dimer and diffusion-weighted imaging pattern as two diagnostic indicators for cancer-related stroke: A case-control study based on the STROBE guidelines.
Shen Y; Li Y; Chen C; Wang W; Li T
Medicine (Baltimore); 2020 Jan; 99(4):e18779. PubMed ID: 31977868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
